iRhythm Technologies Gains Additional Market Shares With AI-Supported Wearable Heart Monitoring Devices

Reading Time: 2 minutes
iRhythm Technologies (IRTC) delivers its Zio products, wearable ECG patches for 14 days of continuous heart rhythm monitoring, enabling faster and more accurate diagnoses through AI-supported data analysis. According to the AVALON study, traditional Holter devices can overlook critical arrhythmias during the usual monitoring period of 24 to 48 hours. In the United States, there is a potential user base of 27 million, with market shares already at 30%. Mordor Intelligence predicts that the market for wearable heart monitoring devices will nearly...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.